Substance-Related Disorders  >>  dronabinol oral  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dronabinol oral / Generic mfg.
Domino, NCT01024335: Dronabinol Naltrexone Treatment for Opioid Dependence

Completed
2/3
60
US
injectable naltrexone and dronabinol, Naltrexone and placebo
New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA)
Opioid Dependence
12/12
12/12
D-LUCS, NCT01020019: Combined Pharmacotherapy for Cannabis Dependency

Completed
2/3
156
US
Dronabinol, Marinol, Placebo, Lofexidine
New York State Psychiatric Institute, National Institute on Drug Abuse (NIDA)
Cannabis Dependence, Marijuana Dependence
09/14
09/14
NCT01598896: Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia

Terminated
2/3
12
US
Dronabinol, Marinol, CSA Drug Code 7369, Schedule III, NDC 54868-3189-0, Clonidine, Catapres, NDC 16590-266-30, Placebo
Mclean Hospital, Brain & Behavior Research Foundation
Cannabis Dependence, Marijuana Dependence
08/17
08/17

Download Options